Right ventricular dysfunction during chemotherapy in patients with breast cancer
Aim. To assess the right ventricle (RV) during chemotherapy (CT) in patients with breast cancer (BC).Material and methods. The study included 40 women aged 35-72 years with BC who underwent anthracycline chemotherapy. The main group (n=40) included women with BC, examined at the first contact, 37 of...
Main Authors: | A. N. Sumin, Yu. S. Slepynina, А. V. Shcheglova, A. V. Ivanova, O. M. Polikutina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2022-06-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/3182 |
Similar Items
-
CIRCULATION MICRORNA AS A POSSIBLE PREDICTOR OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY
by: Maria Vladimirovna Khutornaya, et al.
Published: (2023-09-01) -
Regional'naya programma lecheniya bol'nykh pervichno-generalizovannym i metastaticheskim rakom molochnoy zhelezy
by: - -
Published: (2007-09-01) -
CARDIOVASCULAR COMPLICATIONS OF ANTITUMOR THERAPY FOR BREAST CANCER: DIAGNOSIS, PREVENTION AND TREATMENT
by: V. I. Potievskaya, et al.
Published: (2021-10-01) -
Relationship between cardiac arrhythmias and anticancer therapy
by: V. I. Potievskaya, et al.
Published: (2020-11-01) -
Place of pegylated liposomal doxorubicin in the therapy of metastatic breast cancer
by: E. V. Artamonova
Published: (2016-09-01)